These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7708273

  • 1. High-dose oral calcitriol and zero calcium peritoneal solutions in CAPD patients with refractory secondary hyperparathyroidism.
    Malberti F, Scanziani R, Corradi B, Dozio B, Bonforte G, Imbasciati E, Surian M.
    Nephrol Dial Transplant; 1994; 9(12):1813-5. PubMed ID: 7708273
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pulse intravenous calcitriol therapy of secondary hyperparathyroidism in peritoneal dialysis patients.
    Wadhwa NK, Suh H, Howell N, Cabralda T, Sokunbi D, Solomon M.
    Adv Perit Dial; 1993 Nov; 9():260-3. PubMed ID: 8105939
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism.
    Caravaca F, Cubero JJ, Jimenez F, López JM, Aparicio A, Cid MC, Pizarro JL, Liso J, Santos I.
    Nephrol Dial Transplant; 1995 Nov; 10(5):665-70. PubMed ID: 7566580
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
    Romanini D, Gazo A, Bellazzi R, de Vincenzi A, Nai M, Santagostino M.
    Adv Perit Dial; 1994 Nov; 10():267-9. PubMed ID: 7999842
    [Abstract] [Full Text] [Related]

  • 13. Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol.
    Malberti F, Surian M, Cosci P.
    Kidney Int Suppl; 1993 Jun; 41():S125-30. PubMed ID: 8320905
    [Abstract] [Full Text] [Related]

  • 14. Frequent recurrence of secondary hyperparathyroidism after pulse oral calcitriol withdrawal in PD patients.
    Bajo MA, Selgas R, Possante C, Aguilera A, Sánchez C, Diaz C, de Alvaro F, Martinez ME.
    Adv Perit Dial; 1997 Jun; 13():239-43. PubMed ID: 9360690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S, Brandi L, Olgaard K.
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [Abstract] [Full Text] [Related]

  • 17. [Pulsed doses of calcitriol in the treatment of secondary hyperparathyroidism in patients on hemodialysis].
    Sotorník I, Petrásek R, Schück O, Adamec M, Smrcková I, Tocík J.
    Vnitr Lek; 1997 Sep; 43(9):584-91. PubMed ID: 9750467
    [Abstract] [Full Text] [Related]

  • 18. Effect of calcitriol replacement on serum calcitonin and parathyroid hormone levels in CAPD patients.
    Quesada JM, Rodriguez M, Calderon de la Barca JM, Alvarez-Lara A, Martín-Malo A, Mateo A, Martinez ME, Aljama P.
    Nephrol Dial Transplant; 1995 Sep; 10(1):70-4. PubMed ID: 7724033
    [Abstract] [Full Text] [Related]

  • 19. Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients.
    Liou HH, Chiang SS, Huang TP, Shieh SD, Akmal M.
    Miner Electrolyte Metab; 1994 Sep; 20(3):97-102. PubMed ID: 7816008
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.